| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Medical Officer
2 companies
Bowden Christopher is a Director at TCRT with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 19 sells.
Estimated insider holdings value: $639K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 15, 2019 | AGIO Agios Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 10,000 | $64.16 | $641,615.00 | -38.8% | |
| Aug 30, 2018 | AGIO Agios Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 2,000 | $80.03 | $160,051.00 | -52.0% | |
| Jul 10, 2018 | AGIO Agios Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 2,000 | $86.76 | $173,512.00 | -43.0% | |
| Jun 12, 2018 | AGIO Agios Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 2,000 | $92.89 | $185,786.00 | -50.5% | |
| May 11, 2018 | AGIO Agios Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 2,000 | $85.00 | $170,002.80 | -40.6% | |
| May 8, 2018 | AGIO Agios Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 2,000 | $81.38 | $162,760.00 | -69.4% | |
| Apr 12, 2018 | AGIO Agios Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 2,000 | $85.10 | $170,190.00 | -44.8% | |
| Mar 14, 2018 | AGIO Agios Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 2,000 | $82.33 | $164,661.00 | -49.2% | |
| Feb 16, 2018 | AGIO Agios Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 2,000 | $77.65 | $155,305.00 | -46.9% | |
| Feb 1, 2018 | AGIO Agios Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 2,000 | $78.75 | $157,500.05 | -45.0% |